View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


National Cancer Institute and Merck Research Labs Guests on Pharma Talk Radio Discussing the Exciting Potential and Challenges with Immuno-Oncology

  • June 5, 2015

  • Immuno-Oncology is arguably the most exciting area in the advancement of science and patient care today.  However, with all research, there are plenty of challenges and to get a better understanding of this innovative approach to cancer research, we were pleased to welcome to Pharma Talk Radio, James Gulley, MD, PhD of the National Cancer Institute and Roy Baynes, MD, PhD at Merck Research Labs. Joining Drs Gulley and Baynes was Kate Woda, Director of the IO360 conference taking place at Columbia University Faculty House on June 29-30 in NYC.

    Valerie Bowling, Conference Director, CMOW SummitHost:
    Valerie Bowling, Producer, Pharma Talk Radio



    James Gulley BWJames Gulley, MD, PhD, Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute


    Roy Baynes B&WRoy Baynes, MD, PhD, Senior Vice President, Global Clinical Development, Merck Research Labs



    Kate Woda B&WKate Woda, Director, IO 360




    Listen to the Episode:

    For more details on Immuno-Oncology 360 visit: